June 3, 2014
June 3, 2014
Docket No. FDA-2014-N-0189
I am resubmitting the following public comment, submitted to an earlier docket:
Grana, R., Ling, P.M., Barnes, R.L., Lempert, L., Glantz, S.A. (2013). Comment submitted regarding Feed and Drug Administration actions related to Nicotine Replacement Therapies and smoking-cessation products; report to Congress on innovative products and treatments for tobacco dependence; public hearing; extension of comment period. tracking # 1jx-835b-n9ph.
This comment is referenced in the following comment, which was just submitted to the current docket: FDA Should Prohibit E-cigarette Marketing that Promotes False Health Claims, tracking number 1jy-8cgs-l1sq
Stanton A. Glantz, PhD
Professor of Medicine
This is comment number 1jy-8cgt-ek20. (This file has all the advertising examples in it.)
June 3, 2014
A group of scientists from UCSF and Stanford, led by Lauren Dutra, has submitted a comment to the FDA calling on the agency to block current false advertising by e-cigarette companies and also include such prohibitions in the current deeming rule.
Here is the comment (without the illustrations, which you can get by dowloading the PDF of the comment).
FDA Should Prohibit E-cigarette Marketing that Promotes False Health Claims
Docket No. FDA-2014-N-0189
LM Dutra, ScD1; RA Grana, PhD1; L Lempert, JD1; JK Cataldo, RN, PhD1; SA Glantz, PhD1; BL Halpern-Felsher, PhD2; PM Ling, MD1; L Popova, PhD1; M Walsh, EdD1
1 Center for Tobacco Control Research and Education
University of California San Francisco
2 Department of Pediatrics, Stanford University
June 3, 2014
June 2, 2014
Today, June 3, 2014, Rachel Barry, Heikki Hiilamo, and I published "Waiting for the Opportune Moment: The Tobacco Industry and Marijuana Legalization" in Millbank Quarterly.
Here is Millbank Quarterly's press release on the paper.
Tobacco Companies Were Waiting for the Opportune Moment - the Legalization of Marijuana
Documents Reveal that “Pot” Was Both A Rival and Potential Product
New York, New York, June 3—It turns out that the history of Big Tobacco companies and marijuana is more intertwined than was previously known, according to a new study in The Milbank Quarterly. Based on previously secret tobacco industry documents, the study reveals that, since at least the 1970s, tobacco companies have been interested in marijuana as both a rival and potential product.
June 2, 2014
Jennifer Duke and colleagues just published "Exposure to Electronic Cigarette Television Advertisement Among Youth and Young Adults" in Pediatrics. This paper shows major penetration into the youth market.
Here is the abstract:
BACKGROUND AND OBJECTIVE: Currently, the US Food and Drug Administration does not regulate electronic cigarette (e-cigarette) marketing unless it is advertised as a smoking cessation aid. To date, the extent to which youth and young adults are exposed to e-cigarette television advertisements is unknown. The objective of this study was to analyze trends in youth and young adult exposure to e-cigarette television advertisements in the United States.
METHODS: Nielsen data on television household audiences’ exposure to e-cigarette advertising across US markets were examined by calendar quarter, year, and sponsor.
June 2, 2014
Lauren Lempert and I submitted a public comment today opposing FDA's "Option 2" to exempt "premium cigars" from regulation. Here is what we submitted:
In its proposed deeming rule, FDA solicits public comment on a proposal (Option 2) to exempt a subset of cigars (“premium cigars”) from regulation. Option 2 is not appropriate for the protection of the public health, and would result in negative public health consequences. Indeed, all the scientific evident that the FDA summarizes in the draft rule makes a compelling case for rejecting Option 2 and including all cigars among deemed products that will be subject to uniform regulations.